Trial Watch: Toll-like receptor agonists in cancer immunotherapy

Author:

Smith Melody1,García-Martínez Elena2,Pitter Michael R.1,Fucikova Jitka34,Spisek Radek34,Zitvogel Laurence5678,Kroemer Guido910111213ORCID,Galluzzi Lorenzo91415

Affiliation:

1. Department of Medicine and Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA

2. Hematology and Oncology Department, Hospital Universitario Morales Meseguer, Murcia, Spain

3. Sotio a.c., Prague, Czech Republic

4. Department of Immunology, 2nd Faculty of Medicine, University Hospital Motol, Charles University, Prague, Czech Republic

5. INSERM, U1015, Villejuif, France

6. Gustave Roussy Comprehensive Cancer Institute, Villejuif, France

7. Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, France

8. Université Paris Sud/Paris XI, Le Kremlin-Bicêtre, France

9. Université Paris Descartes/ Paris V, Paris, France

10. Université Pierre et Marie Curie/Paris VI, Paris, France

11. INSERM, U1138, Paris, France

12. Equipe 11 labellisée Ligue contre le Cancer, Centre de Recherche des Cordeliers, Paris, France

13. Metabolomics and Cell Biology Platforms, Gustave Roussy Comprehensive Cancer Institute, Villejuif, France

14. Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA

15. Sandra and Edward Meyer Cancer Center, New York, NY, USA

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Cited by 168 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3